BCHT.AMEXBirchtech CORP
10-Q: Birchtech Corp. Reports Q1 2025 Results: Revenue Stable, Net Loss Decreases Amidst Water Treatment Expansion
Sentiment:
Quarterly Report
Birchtech Corp.'s Q1 2025 results show stable revenue and a reduced net loss compared to Q1 2024, driven by licensing revenue and cost management, as the company expands into water treatment technologies.
Worse than expectedThe company's working capital deficiency increased, and management expresses substantial doubt about the company's ability to continue as a going concern within one year.
Summary
- Birchtech Corp. reported a net loss of $1.679 million for the three months ended March 31, 2025, compared to a net loss of $2.855 million for the same period in 2024.
- Revenue remained relatively stable at $3.221 million in Q1 2025 versus $3.242 million in Q1 2024.
- The company's Q1 2025 product revenue was $2.677 million, while license revenue increased to $525,000.
- Operating expenses decreased from $3.527 million in Q1 2024 to $2.577 million in Q1 2025.
- The company is expanding into water treatment technologies, supported by two new state-of-the-art laboratories.
- Birchtech is pursuing patent litigation to protect its mercury emissions reduction technologies.
- The company's cash balance was $3.188 million as of March 31, 2025, with a working capital deficiency of $4.279 million.
- Management acknowledges substantial doubt about the company's ability to continue as a going concern within one year.
- A share repurchase program for up to $5.0 million of common stock has been authorized, with repurchases anticipated in the second half of 2025.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While the net loss decreased and licensing revenue increased, the company faces significant financial challenges, including a working capital deficiency and doubts about its ability to continue as a going concern. The potential for future cash inflows from patent litigation and the expansion into water treatment offer some optimism, but the overall sentiment is cautious.
Positives
- The net loss decreased significantly year-over-year, indicating improved financial performance.
- Licensing revenue increased substantially, suggesting successful commercialization of intellectual property.
- Operating expenses were reduced, reflecting cost management efforts.
- The company is expanding into the water treatment market, diversifying its revenue streams.
- Birchtech secured a $57.1 million jury verdict in a patent infringement case, potentially providing a significant cash inflow.
- A share repurchase program has been authorized, which could support the stock price.
Negatives
- The company continues to operate at a net loss.
- The company has a significant working capital deficiency.
- Management expresses substantial doubt about the company's ability to continue as a going concern within one year.
- The company is reliant on the outcome of patent litigation for future cash inflows.
- The company's disclosure controls and procedures were not effective as a result of material weaknesses in our internal control over financial reporting.
Risks
- The company's ability to continue as a going concern is uncertain.
- The company is dependent on the outcome of ongoing patent litigation.
- Changes in environmental regulations could impact the demand for mercury emissions control technologies.
- The company faces risks associated with rising material costs in its fixed-price contracts.
- The company's disclosure controls and procedures were not effective as a result of material weaknesses in our internal control over financial reporting.
Future Outlook
The company plans to mitigate its financial condition by receiving additional cash inflows from the judgment expected in connection with the $57.1 million jury verdict, additional licensing revenues and product sales from other patent litigation, and revenues from its entry into the water treatment business. Management is also exploring additional financing opportunities.
Management Comments
- Management acknowledges substantial doubt about the company's ability to continue as a going concern within one year.
- Management believes plans to alleviate substantial doubt, but there is no assurance that they will be successfully realized or implemented.
Industry Context
The company operates in the specialty activated carbon technologies market, focusing on mercury emissions capture for coal-fired utilities and developing water purification technologies. The EPA's MATS rule and the new drinking water standards for PFAS are key drivers for the company's business. The company's expansion into water treatment aligns with growing concerns about PFAS contamination and the need for effective remediation technologies.
Comparison to Industry Standards
- The company's performance can be compared to competitors in the activated carbon and water treatment industries, such as Cabot Corporation, Calgon Carbon Corporation (a subsidiary of Kuraray Co., Ltd.), and Evoqua Water Technologies Corp.
- These companies also provide activated carbon solutions for various applications, including air and water purification.
- Birchtech's focus on specialty activated carbon technologies and its patented SEA process for mercury removal differentiate it from competitors.
- The company's expansion into water treatment with a focus on PFAS remediation positions it to capitalize on the growing demand for these technologies.
- The $57.1 million jury verdict in the patent infringement case highlights the value of the company's intellectual property and its ability to enforce its patent rights.
Legal Proceedings
- The company is involved in multiple patent infringement lawsuits related to its mercury emissions reduction technologies.
- A federal jury awarded the company $57.1 million in a patent infringement case against CERT defendants.
- The company has entered into licensing agreements with some utilities named as defendants in patent infringement lawsuits.
- The company is awaiting rulings from the Court regarding post-trial motions and applications related to the $57.1 million jury verdict.
Related Party Transactions
- Kaye Cooper Kay & Rosenberg, LLP provides certain legal services to the Company and was paid $112,500 for the three months ended March 31, 2025.
- David M. Kaye, a Director of the Company, is a partner of the law firm.
- Dakin Holdings Ltd., a company owned and controlled by the Company's Chief Executive Officer and President, has granted to the Company (i) a limited license to manufacture and produce for Dakin products comprising certain intellectual property owned by Dakin (the Dakin IP), and (ii) an exclusive license to commercialize the Dakin IP in the United States.
Stakeholder Impact
- Shareholders face uncertainty due to the company's financial challenges and dependence on patent litigation.
- Employees may be affected by potential cost-cutting measures or restructuring.
- Customers in the coal-fired utility sector may benefit from the company's mercury emissions reduction technologies.
- Customers in the water treatment market may benefit from the company's new sorbent technologies.
- Suppliers may be impacted by changes in the company's purchasing patterns.
Next Steps
- The company awaits rulings from the Court regarding post-trial motions and applications related to the $57.1 million jury verdict.
- The company will continue to pursue patent litigation against infringers of its mercury emissions reduction technologies.
- The company will continue to develop and commercialize its water treatment technologies.
- The company anticipates that any repurchases will not occur before the second half of 2025.
- The company will monitor and respond to any changes in environmental regulations.
Key Dates
| Date | Description |
|---|---|
| 2011-05 | U.S. Environmental Protection Agency (EPA) proposed the Mercury and Air Toxics Standards (MATS) rule. |
| 2012-04 | The MATS rule became effective. |
| 2016-11-29 | The Company closed on a secured note with AC Midwest Energy, LLC (AC Midwest). |
| 2019-07-17 | The Company initiated patent litigation against certain defendants in the U.S. District Court for the District of Delaware. |
| 2023-01 | A decision was made in January 2023 to liquidate ME2C Sponsor LLC and ME2C Acquisition Corp. which are inactive. |
| 2023-04 | The EPA issued a proposal to strengthen and update MATS. |
| 2023-07-03 | The Board of Directors of the Company approved and adopted the Companys Amended and Restated 2014 Equity Incentive Plan (the 2014 Plan) and the Companys Amended and Restated 2017 Equity Incentive Plan (the 2017 Plan). |
| 2023-11-09 | The Company entered into a confidential binding term sheet with Arthur J. Gallagher & Co., and various of its affiliated entities (collectively AJG), and DTE Energy Resources LLC and various of its affiliated entities (collectively DTE), to resolve the patent litigation. |
| 2023-12-28 | The Company, along with its wholly-owned subsidiary, MES, Inc., and (a) Chem-Mod LLC (Chem-Mod), (b) Arthur J. Gallagher & Co. and AJG Coal, LLC, and (c) DTE Energy Co. and DTE Energy Resources, LLC, entered into a paid license of U.S. Patent No. 8,168,147, U.S. Patent No. 10,343,114, U.S. Patent No. 10,589,225, U.S. Patent No. 10,596,517 and U.S. Patent No. 10,668,430 and their foreign equivalents and related patent applications and patents, which licenses the use of refined coal or the Chem-Mod Solution in conjunction with activated carbon. |
| 2024-02-27 | The Company paid AC Midwest $275,625 representing the remaining principal balance under the AC Midwest Secured Note of $271,686 plus interest of $3,939. |
| 2024-02-27 | The Company entered into an Unsecured Debt Restructuring Agreement (the Debt Restructuring Agreement) with AC Midwest which replaces and supersedes the Unsecured Note Financing Agreement. |
| 2024-03-01 | A federal jury in the U.S. District Court for the District of Delaware awarded a $57.1 million patent infringement verdict in favor of the Company against the remaining group of CERT defendants. |
| 2024-03-11 | The private sale of shares for the purchase price of $960,000 was completed on March 11, 2024. |
| 2024-03-28 | The lease was further extended for an additional five years from March 31, 2024 to March 31, 2029. |
| 2024-04 | The EPA issued the first-ever national, enforceable drinking water standard to protect communities from exposure to harmful per-and polyfluoroalkyl substances (PFAS), also known as forever chemicals. |
| 2024-04 | The Company announced the introduction of our new division to address the potable (drinking) water market with new sorbent technologies under development. |
| 2024-05 | The EPA finalized and published the proposal to strengthen and update MATS with an effective date of July 8, 2024. |
| 2024-05 | The Company announced the appointment of David Mazyck to head our new division to address the potable (drinking) water market with new sorbent technologies under development. |
| 2024-05 | The Company announced the appointment of Dennis Baranik as Director of National Sales. |
| 2024-06-24 | The Company issued (i) 886,456 shares of common stock to the Companys Chief Executive Officer upon a cashless exercise of an option to purchase 1,500,000 shares of common stock at an exercise price of $0.27 per share, and (ii) 672,867 shares of common stock to the Companys Senior Vice President and Chief Technology Officer upon a cashless exercise of options to purchase an aggregate of 1,600,000 shares of common stock at exercise prices ranging from $0.27 to $0.45 per share. |
| 2024-06-28 | The Company issued (i) 46,409 shares of common stock to an employee upon a cashless exercise of options to purchase an aggregate of 300,000 shares of common stock at exercise prices ranging from $0.27 to $0.61 per share, (ii) 44,065 shares of common stock to an employee upon a cashless exercise of an option to purchase 75,000 shares of common stock covered by an option to purchase a total of 100,000 shares of common stock with an exercise price of $0.27 per share, and (iii) 15,000 shares of common stock to a former employee upon a cashless exercise of an option to purchase 25,531 shares of common stock covered by an option to purchase a total of 500,000 shares of common stock with an exercise price of $0.27 per share. |
| 2024-07 | The Company commenced three patent infringement lawsuits against 14 defendants, including coal-fired power utilities, in three separate U.S. District Courts in Arizona, Iowa and Missouri. |
| 2024-08-01 | The Company entered into a 3-year lease for laboratory space in Grand Forks, North Dakota. |
| 2024-08-03 | The Company issued 32,112 shares of common stock to a former consultant upon a cashless exercise of an option to purchase 62,500 shares of common stock, with an exercise price of $0.40 per share. |
| 2024-08-26 | The Company repaid AC Midwest the remaining principal of $3,154,931 on the New Note together with accrued interest of $119,964. |
| 2024-10-08 | The Company entered into agreement with one of the utilities and an affiliated entity named as defendants in the patent infringement lawsuit commenced by the Company in July 2024 in Arizona. |
| 2024-10-09 | The Company received conditional approval to list our shares of common stock on the Toronto Stock Exchange (TSX) and graduate from the TSX Venture Exchange (TSXV) to the TSX. |
| 2024-10-17 | The Company changed its corporate name from Midwest Energy Emissions Corp. to Birchtech Corp. |
| 2024-10-29 | The Board approved certain non-material amendments to the 2014 Plan and 2017 Plan which amendments were made in connection with the listing of the Companys shares on the Toronto Stock Exchange (TSX) and graduation from the TSX Venture Exchange to the TSX. |
| 2024-11-12 | The Company's shares commenced trading on the TSX under the ticker symbol BCHT. |
| 2024-11-22 | The Company entered into an approximate 3-year lease for laboratory space in State College, Pennsylvania, commencing December 15, 2024 and ending November 30, 2027. |
| 2024-12-17 | A United States Judicial Panel on Multidistrict Litigation ordered that the above three patent infringement lawsuits be consolidated and centralized in the Southern District of Iowa for coordinated or consolidated pretrial proceedings (the Transfer Order). |
| 2025-01-01 | Birchtech Corp. entered into an investor relations consulting agreement with MZHCI, LLC. |
| 2025-01-07 | The Company entered into agreement with another one of the utilities named as a defendant in the Arizona action. |
| 2025-01 | The Company commenced another patent infringement lawsuit against four defendants in the U.S. District Court for the Western District of Missouri. |
| 2025-01-15 | The Company issued 50,000 shares of common stock to a director due to the vesting on such date of 50,000 restricted share units (RSUs) which had previously been granted on January 15, 2024 and had a one-year vesting period. |
| 2025-02 | The lawsuit commenced in January 2025 was consolidated with and transferred to the Southern District of Iowa pursuant to the Transfer Order. |
| 2025-03-12 | The newly appointed EPA administrator under the Trump Administration announced plans to roll back dozens of environmental regulations including the reconsideration of the MATS regulation. |
| 2025-03-19 | The Company announced that its Board of Directors authorized a share repurchase program under which the Company may purchase up to $5.0 million of its common stock. |
| 2025-04-08 | President Trump signed a Proclamation exempting certain stationary sources, identified in Annex 1 of the Proclamation, from compliance with the 2024 updated MATS Rule. |
| 2027-07-08 | The Presidents exemption lasts for a period of two years beyond the updated Rules compliance date -i.e., for the period beginning July 8, 2027, and concluding July 8, 2029. |
| 2029-07-08 | The Presidents exemption lasts for a period of two years beyond the updated Rules compliance date -i.e., for the period beginning July 8, 2027, and concluding July 8, 2029. |
Keywords
Birchtech, patent litigation, water treatment, mercury emissions, financial results, net loss, revenue, licensing, operating expenses, going concern, share repurchase, PFAS, activated carbon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.